Search Results - "Hustache-Mathieu L"

Facteurs de risque de syndrome d'hypersensibilité à l'Abacavir en pratique clinique de routine

Alternate Title: Risk factors for Abacavir-induced hypersensibility syndrome in the “real world”

Authors: Chirouze, C. Hustache-Mathieu, L. Rougeot, C. et al.

Source: Pathologie Biologie. Nov2004, Vol. 52 Issue 9, p529-533. 5p.

Increased incidence of diabetes in people living with HIV treated with first‐line integrase strand transfer inhibitors: A French multicentre retrospective study.

Authors: Ursenbach, Axel Sireyjol, Antoine Delpierre, Cyrille et al.

Source: HIV Medicine. Jan2025, Vol. 26 Issue 1, p166-172. 7p.

No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy.

Authors: Lajaunie, Rébecca Cuzin, Lise Palich, Romain et al.

Source: HIV Medicine. Mar2022, Vol. 23 Issue 3, p301-306. 6p.

W-05 Consultation d’éducation thérapeutique au CHUR de Besançon : 5 années d’expérience

Authors: Hustache-Mathieu, L. Genton, S. Essert, M. et al.

Source: Medecine & Maladies Infectieuses. Jun2008 Supplement 2, Vol. 38, pS190-S191. 0p.

Q-04 Péricardite méningococcique primitive à méningocoque C

Authors: Roncato-Sabéran, M. Hustache-Mathieu, L. Chirouze, C. et al.

Source: Medecine & Maladies Infectieuses. Jun2008 Supplement 2, Vol. 38, pS177-S177. 1p.

Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.

Authors: Tron, L Lert, F Spire, B et al.

Source: HIV Medicine. Mar2017, Vol. 18 Issue 3, p181-195. 15p.

Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.

Authors: Poizot‐Martin, I. Obry‐Roguet, V. Duvivier, C. et al.

Source: Journal of the European Academy of Dermatology & Venereology. May2020, Vol. 34 Issue 5, p1065-1073. 9p.

Connaissance des référentiels intra-hospitaliers d’infectiologie en CHU.

Authors: Bailly, B. Chirouze, C. Hustache Mathieu, L. et al.

Source: Medecine & Maladies Infectieuses. Jun2017 Supplement, Vol. 47, pS35-S35. 1p.

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.

Authors: Lions, C. Cabras, O. Cotte, L. et al.

Source: BMC Infectious Diseases. 3/25/2019, Vol. 19 Issue 1, pN.PAG-N.PAG. 1p. 3 Charts.

Étude des infections à VIH nouvellement découvertes entre 2000 et 2007 dans le Nord et l’Est de la France

Alternate Title: Study of new HIV infection between 2000 and 2007 in the north and east of France

Authors: Henard, S. Letranchant, L. Borel, A. et al.

Source: Medecine & Maladies Infectieuses. Sep2010, Vol. 40 Issue 9, p517-523. 7p.

Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections.

Authors: Faucher, J.-F. Bellanger, A.-P. Shaniya, N. et al.

Source: Medecine & Maladies Infectieuses. Aug2014, Vol. 44 Issue 8, p387-389. 3p.

Suspicion de borréliose de Lyme : parcours de soins avant la consultation en infectiologie et apport de l’infectiologue.

Authors: Voitey, M. Bouiller, K. Moreau, J. et al.

Source: Medecine & Maladies Infectieuses. Jun2018:Supplement, Vol. 48, pS14-S14. 1p.

L-04: Enquête sur l’application en routine des recommandations pour le traitement curatif des accès à Plasmodium vivax/ovale.

Authors: Faucher, J.-F. Bellanger, A.-P. Niyaz, S. et al.

Source: Medecine & Maladies Infectieuses. Jun2014, Vol. 44 Issue S, p61-61. 1p.

L-14: Traitements courts par ceftriaxone dans la leptospirose : étude rétrospective monocentrique.

Authors: Faucher, J.-F. Chirouze, C. Hoen, B. et al.

Source: Medecine & Maladies Infectieuses. Jun2014, Vol. 44 Issue S, p63-63. 1p.

M-04 La procalcitonine sérique ne permet pas de discriminer entre fièvre hémorragique avec syndrome rénal et leptospirose

Authors: Studer, B. Chirouze, C. Bermont, L. et al.

Source: Medecine & Maladies Infectieuses. Jun2009, Vol. 39, pS58-S58. 1p.

Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis.

Authors: Gantner P Hessamfar M Souala MF et al.

Corporate Authors: Gantner P Hessamfar M Souala MF et al.

Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Feb 14; Vol. 70 (5), pp. 943-946.

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

Authors: Virlogeux V Zoulim F Pugliese P et al.

Corporate Authors: Virlogeux V Zoulim F Pugliese P et al.

Source: BMC medicine [BMC Med] 2017 Dec 18; Vol. 15 (1), pp. 217. Date of Electronic Publication: 2017 Dec 18.

Publication Type: Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

Number, type and cost of microbiological tests during HIV Pre-Exposure Prophylaxis: The experience of a French hospital.

Authors: Morgat M Bouiller K Vuillemenot JB et al.

Source: Infectious diseases now [Infect Dis Now] 2021 Jun; Vol. 51 (4), pp. 357-361. Date of Electronic Publication: 2020 Oct 20.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 101775152 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-9919 (Electronic) Linking ISSN: 26669919 NLM ISO Abbreviation: Infect Dis Now Subsets: MEDLINE

Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients.

Authors: Lagoutte-Renosi J Flammang M Chirouze C et al.

Source: Current HIV research [Curr HIV Res] 2021; Vol. 19 (1), pp. 84-89.

Publication Type: Comparative Study; Journal Article

Journal Info: Publisher: Bentham Science Publishers Country of Publication: Netherlands NLM ID: 101156990 Publication Model: Print Cited Medium: Internet ISSN: 1873-4251 (Electronic) Linking ISSN: 1570162X NLM ISO Abbreviation: Curr HIV Res Subsets: MEDLINE

Brill-Zinsser disease in Moroccan man, France, 2011.

Authors: Faucher JF Socolovschi C Aubry C et al.

Source: Emerging infectious diseases [Emerg Infect Dis] 2012 Jan; Vol. 18 (1), pp. 171-2.

Publication Type: Letter

Journal Info: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE